2024 Global Hematology and Flow Cytometry Market: Latest Analyzers and Strategic Profiles of Leading Suppliers
This 65-page report reviews current instrumentation technologies, and compares features of leading hematology and flow cytometry analyzers.
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. INFLUENZA VIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. LEGIONELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. MONONUCLEOSIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. MYCOPLASMA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. PNEUMONIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. RESPIRATORY SYNCYTIAL VIRUS (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. TUBERCULOSIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Table of Contents (continued)
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
III. Country Analysis: Market Size, Growth and Major
Suppliers’ Sales and Market Shares
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. INFLUENZA VIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. LEGIONELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. MONONUCLEOSIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. MYCOPLASMA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. PNEUMONIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. RESPIRATORY SYNCYTIAL VIRUS (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. TUBERCULOSIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Table of Contents (continued)
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
III. Country Analysis: Market Size, Growth and Major
Suppliers’ Sales and Market Shares
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
